[Skip to Content]
[Skip to Content Landing]
Medical News and Perspectives
May 17, 2006

New Markers May Help Predict Prostate Cancer Relapse Risk

JAMA. 2006;295(19):2234-2238. doi:10.1001/jama.295.19.2234

After cancer diagnosis and treatment, the most looming concern expressed by most patients is their risk of recurrence. In the case of prostate cancer, despite screening techniques that include physical examinations, prostate-specific antigen (PSA) tests, and Gleason scoring (a grading system based on cancer cells' appearance under a microscope), oncologists often struggle with accurately stratifying patients as low-, intermediate-, and high-risk. For example, it is not clear why, following prostatectomy, some men's PSA levels rise again while others' do not.

First Page Preview View Large
First page PDF preview
First page PDF preview